Fulgent Genetics, Inc. Quarterly Debt-to-equity in % from Q2 2017 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Fulgent Genetics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2017 to Q2 2024.
Fulgent Genetics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 8.7 %, a 0.35% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	8.7	+0.03	+0.35%	Jun 30, 2024
Q1 2024	8.22	-1.55	-15.9%	Mar 31, 2024
Q4 2023	8.09	-2.47	-23.4%	Dec 31, 2023
Q3 2023	8.16	-2.56	-23.9%	Sep 30, 2023
Q2 2023	8.68	-3.32	-27.7%	Jun 30, 2023
Q1 2023	9.77	-2.8	-22.3%	Mar 31, 2023
Q4 2022	10.6	-4.78	-31.2%	Dec 31, 2022
Q3 2022	10.7	-7.89	-42.4%	Sep 30, 2022
Q2 2022	12	-8.97	-42.8%	Jun 30, 2022
Q1 2022	12.6	-11.6	-48%	Mar 31, 2022
Q4 2021	15.3	-7.18	-31.9%	Dec 31, 2021
Q3 2021	18.6	-0.37	-1.95%	Sep 30, 2021
Q2 2021	21	+11.4	+118%	Jun 30, 2021
Q1 2021	24.2	+14.6	+153%	Mar 31, 2021
Q4 2020	22.5	+12.6	+128%	Dec 31, 2020
Q3 2020	19	+9.14	+92.8%	Sep 30, 2020
Q2 2020	9.62	+1.81	+23.2%	Jun 30, 2020
Q1 2020	9.58	+2.94	+44.3%	Mar 31, 2020
Q4 2019	9.89	+4.91	+98.6%	Dec 31, 2019
Q3 2019	9.84	+4.82	+95.9%	Sep 30, 2019
Q2 2019	7.81	+2.32	+42.3%	Jun 30, 2019
Q1 2019	6.64	+1.19	+21.8%	Mar 31, 2019
Q4 2018	4.98	-0.92	-15.6%	Dec 31, 2018
Q3 2018	5.03	-1.11	-18.1%	Sep 30, 2018
Q2 2018	5.49	-3.08	-35.9%	Jun 30, 2018
Q1 2018	5.45			Mar 31, 2018
Q4 2017	5.9			Dec 31, 2017
Q3 2017	6.14			Sep 30, 2017
Q2 2017	8.57			Jun 30, 2017

* An asterisk sign (*) next to the value indicates that the value is likely invalid.